Related Experiment Videos
Erythropoietic protoporphyria and terminal hepatic failure
D Bruch-Gerharz1, K Bolsen, C D Gerharz
1Department of Dermatology, Heinrich-Heine-University of Duesseldorf, Germany.
Acta Dermato-Venereologica
|November 1, 1996
Summary
Erythropoietic protoporphyria (EPP) can be managed with oral carotinoids, controlling photosensitivity for decades. However, unpredictable liver complications can arise, potentially leading to fatal hepatic failure.
Area of Science:
- Biochemistry
- Hepatology
- Dermatology
Background:
- Erythropoietic protoporphyria (EPP) is a rare genetic disorder characterized by photosensitivity.
- Management typically focuses on symptom control and preventing sun exposure.
Observation:
- A 44-year-old patient with EPP utilized oral carotinoids for 22 years to manage photosensitivity.
- The patient developed liver involvement, initially with elevated transaminases, progressing to terminal hepatic failure over 22 years.
Findings:
- Oral carotinoids provided long-term control of photosensitivity in EPP.
- Hepatic involvement in EPP is an unpredictable complication that significantly impacts prognosis.
- Terminal hepatic failure developed 22 years after the initial signs of liver dysfunction.
Implications:
- This case highlights the potential long-term efficacy of carotinoids in EPP management.
- It underscores the critical need for monitoring liver function in EPP patients due to unpredictable complications.
- Prognosis in EPP is significantly influenced by the development and severity of hepatic involvement.